Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
T. Moriyama, T. Matsumoto, T. Fuchigami, S. Nakamura, N. Ishikawa, N. Takubo, S. Yamamoto, Y. Oshiro, M. Nakanishi, K. Tomioka & M. Iida. (2004) Changes in Helicobacter pylori status in patients with rheumatoid arthritis under non‐steroidal anti‐inflammatory drugs. Scandinavian Journal of Gastroenterology 39:2, pages 111-118.
Read now
Read now
Articles from other publishers (33)
Natalie Patel, Prasenjit Das & Dhanpat Jain. 2022. Surgical Pathology of the Gastrointestinal System. Surgical Pathology of the Gastrointestinal System
521
572
.
Masoud Youssefi, Mohsen Tafaghodi, Hadi Farsiani, Kiarash Ghazvini & Masoud Keikha. (2021) Helicobacter pylori infection and autoimmune diseases; Is there an association with systemic lupus erythematosus, rheumatoid arthritis, autoimmune atrophy gastritis and autoimmune pancreatitis? A systematic review and meta-analysis study. Journal of Microbiology, Immunology and Infection 54:3, pages 359-369.
Crossref
Crossref
Hiroshi Satoh, Yasutada Akiba & Tetsuro Urushidani. (2020) Proton Pump Inhibitors Prevent Gastric Antral Ulcers Induced by NSAIDs via Activation of Capsaicin-Sensitive Afferent Nerves in Mice. Digestive Diseases and Sciences 65:9, pages 2580-2594.
Crossref
Crossref
Claudia Mendoza-Pinto, Mario García-Carrasco, Socorro Méndez-Martínez, Tania Mogollán-Delfín, Pamela Munguía-Realpozo, Efrén Herrera-Robles, Ivet Etchegaray-Morales, José Luis Gálvez-Romero, Álvaro Montiel-Jarquín & Aurelio López-Colombo. (2019) Helicobacter pylori infection and gastroduodenal lesions in patients with systemic lupus erythematosus. Clinical Rheumatology 39:2, pages 463-469.
Crossref
Crossref
Aliasghar Ebrahimi, Babak Soofizadeh, Faegheh Ebrahimi, Seyed Yagoob Moaadab, Mohammadreza Bonyadi, Morteza Gojazadeh & Aida Malek Mahdavi. (2019) Relationship between Helicobacter pylori cytotoxin-associated gene A protein with clinical outcomes in patients with rheumatoid arthritis. Immunology Letters 211, pages 49-52.
Crossref
Crossref
Mikhail P. Ponomarenko, Olga Arkova, Dmitry Rasskazov, Petr Ponomarenko, Ludmila Savinkova & Nikolay Kolchanov. (2016) Candidate SNP Markers of Gender-Biased Autoimmune Complications of Monogenic Diseases Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters. Frontiers in Immunology 7.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
236
272
.
Chun‐Li Tang, Feng Ye, Wei Liu, Xiao‐Lin Pan, Juan Qian & Guo‐Xin Zhang. (2012)
Eradication of
Helicobacter pylori
Infection Reduces the Incidence of Peptic Ulcer Disease in Patients using Nonsteroidal Anti‐Inflammatory Drugs: A Meta‐Analysis
. Helicobacter 17:4, pages 286-296.
Crossref
Crossref
K. D. RainsfordK. D. Rainsford. 2012. Ibuprofen: Pharmacology, Therapeutics and Side Effects. Ibuprofen: Pharmacology, Therapeutics and Side Effects
123
139
.
Alexandra N Colebatch, Jonathan L Marks & Christopher J Edwards. (2011) Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis). Cochrane Database of Systematic Reviews.
Crossref
Crossref
K. D. Rainsford. (2009) Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology 17:6, pages 275-342.
Crossref
Crossref
U. Kiltz, J. Zochling, W. E. Schmidt & J. Braun. (2008) Use of NSAIDs and infection with Helicobacter pylori--what does the rheumatologist need to know?. Rheumatology 47:9, pages 1342-1347.
Crossref
Crossref
Larry H. Lai & Joseph J.Y. Sung. (2007) Helicobacter pylori and benign upper digestive disease. Best Practice & Research Clinical Gastroenterology 21:2, pages 261-279.
Crossref
Crossref
Zunwu Zhang. (2008) The Risk of Gastric Cancer in Patients with Duodenal and Gastric Ulcer: Research Progresses and Clinical Implications. Journal of Gastrointestinal Cancer 38:1, pages 38-45.
Crossref
Crossref
Masato Kawabe, Hiroto Miwa, Toshifumi Ohkusa, Tetsuji Yokoyama, Akihiko Kurosawa, Daisuke Asaoka, Mariko Hojo, Akihito Nagahara, Hiroshi Tsuda & Nobuhiro Sato. (2006) Nonsteroidal Anti-Inflammatory Drugs Induce Asymptomatic Gastroduodenal Ulcers in the Japanese Population: A Case-Control Study on Its Prevalence and the Protective Effect of Anti-Ulcer Agents. Journal of Clinical Biochemistry and Nutrition 39:3, pages 145-152.
Crossref
Crossref
. 2006. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions
2555
2582
.
Molly D. Magnano & Mark C. Genovese. (2005) Management of co-morbidities and general medical conditions in patients with rheumatoid arthritis. Current Rheumatology Reports 7:5, pages 407-415.
Crossref
Crossref
Gérard Thiéfin & Damien Jolly. (2004) Impact de l’infection à Helicobacter pylori sur le risque de complications gastro-duodénales des traitements anti-inflammatoires non stéroïdiens. Gastroentérologie Clinique et Biologique 28, pages 45-57.
Crossref
Crossref
M Gallerani, M Simonato, R Manfredini, S Volpato, G.B Vigna & R Fellin. (2004) Risk of hospitalization for upper gastrointestinal tract bleeding. Journal of Clinical Epidemiology 57:1, pages 103-110.
Crossref
Crossref
A. Del Favero. 2004.
102
117
.
David A Owen. (2003) Gastritis and Carditis. Modern Pathology 16:4, pages 325-341.
Crossref
Crossref
A. Lanas, E. Martin-Mola, J. Ponce, F. Navarro, J.M. Piqué & F.J. Blanco. (2003) Estrategia clínica para la prevención de los efectos adversos sobre el tracto digestivo de los antiinflamatorios no esteroideos. Gastroenterología y Hepatología 26:8, pages 485-502.
Crossref
Crossref
J.‐C. Luo, F.‐Y. Chang, H.‐Y. Lin, R.‐H. Lu, C.‐L. Lu, C.‐Y. Chen & S.‐D. Lee. (2002) The potential risk factors leading to peptic ulcer formation in autoimmune disease patients receiving corticosteroid treatment. Alimentary Pharmacology & Therapeutics 16:7, pages 1241-1248.
Crossref
Crossref
A. Lanas, J. Fuentes, R. Benito, P. Serrano, E. Bajador & R. Sáinz. (2002)
Helicobacter pylori
increases the risk of upper gastrointestinal bleeding in patients taking low‐dose aspirin
. Alimentary Pharmacology & Therapeutics 16:4, pages 779-786.
Crossref
Crossref
M. E. Van Leerdam & G. N. J. Tytgat. (2002)
Helicobacter pylori
infection in peptic ulcer haemorrhage
. Alimentary Pharmacology & Therapeutics 16, pages 66-78.
Crossref
Crossref
Jia-Qing Huang, Subbaramiah Sridhar & Richard H Hunt. (2002) Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. The Lancet 359:9300, pages 14-22.
Crossref
Crossref
Natasha May, Joel Epstein & Barrie Osborne. (2001) Selective COX-2 inhibitors: A review of their therapeutic potential and safety in dentistry. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 92:4, pages 399-405.
Crossref
Crossref
Franco Bazzoli, Luca De Luca & David Y. Graham. (2001) Helicobacter pylori infection and the use of NSAIDs. Best Practice & Research Clinical Gastroenterology 15:5, pages 775-785.
Crossref
Crossref
A. Lanas, J.M. Piqué & J. Ponce. (2001) Estrategia clínica para el paciente que precisa antiinflamatorios no esteroides: posición de los inhibidores de la COX-2. Gastroenterología y Hepatología 24:1, pages 22-36.
Crossref
Crossref
Francis K.L Chan, Christopher J Hawkey & Angel I Lanas. (2001) Helicobacter pylori and nonsteroidal anti-inflammatory drugs: a three-way debate. The American Journal of Medicine 110:1, pages S55-S57.
Crossref
Crossref
M. Barr, M. Buckley & C. O'morain. (2000) Non-steroidal anti-inflammatory drugs and Helicobacter pylori. Alimentary Pharmacology & Therapeutics 14, pages 43-47.
Crossref
Crossref
P. Knoflach. (2001) Helicobacter pylori und nichtsteroidale Antirheumatika. Acta Medica Austriaca 27:4, pages 126-128.
Crossref
Crossref
J.-Q. Huang, R. Lad & R. H. Hunt. 2000. Helicobacter pylori. Helicobacter pylori
443
451
.